Mercer Global Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.3K | Hold |
16,726
| – | – | ﹤0.01% | 2175 |
|
|
2025
Q1 | $56.7K | Hold |
16,726
| – | – | ﹤0.01% | 2096 |
|
|
2024
Q4 | $68.9K | Hold |
16,726
| – | – | ﹤0.01% | 2067 |
|
|
2024
Q3 | $40.8K | Hold |
16,726
| – | – | ﹤0.01% | 1925 |
|
|
2024
Q2 | $44.2K | Hold |
16,726
| – | – | ﹤0.01% | 1918 |
|
|
2024
Q1 | $34K | Hold |
16,726
| – | – | ﹤0.01% | 1908 |
|
|
2023
Q4 | $30K | Hold |
16,726
| – | – | ﹤0.01% | 1978 |
|
|
2023
Q3 | $23K | Hold |
16,726
| – | – | ﹤0.01% | 1923 |
|
|
2023
Q2 | $23K | Hold |
16,726
| – | – | ﹤0.01% | 1890 |
|
|
2023
Q1 | $39K | Hold |
16,726
| – | – | ﹤0.01% | 1878 |
|
|
2022
Q4 | $38K | Hold |
16,726
| – | – | ﹤0.01% | 1879 |
|
|
2022
Q3 | $46K | Hold |
16,726
| – | – | ﹤0.01% | 1776 |
|
|
2022
Q2 | $41K | Hold |
16,726
| – | – | ﹤0.01% | 1776 |
|
|
2022
Q1 | $66K | Hold |
16,726
| – | – | ﹤0.01% | 1820 |
|
|
2021
Q4 | $74K | Hold |
16,726
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q3 | $103K | Buy |
+16,726
| New | +$103K | ﹤0.01% | 1680 |
|